Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

Abstract Background Primary retroperitoneal lymph node dissection (RPLND) ultimately lost its role as the standard management of clinical stage (CS) 1 nonseminomatous (NS) testicular germ cell tumours (GCTs) in Europe when the European Germ Cell Cancer Consensus Group released their recommendations...

Full description

Bibliographic Details
Main Authors: K.-P. Dieckmann, P. Anheuser, M. Kulejewski, R. Gehrckens, B. Feyerabend
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Urology
Subjects:
Testicular germ cell tumour
Nonseminomatous tumour
Lymph node dissection
Teratoma
Online Access:http://link.springer.com/article/10.1186/s12894-018-0412-x

Internet

http://link.springer.com/article/10.1186/s12894-018-0412-x

Similar Items